supported by grants from Natural Science Foundation of Liaoning Province(No.201102006)
Objective:To explore inhibition effects of veliparib as PARP inhibitor combined doxorubicin for BEL-7404 proliferation of human liver cancer cell line.Methods:BEL-7404 was taken as the object of study and conventional...